Bank of Montreal’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2M | Sell |
26,585
-9,777
| -27% | -$772K | ﹤0.01% | 1669 |
|
|
2025
Q4 | $2.88M | Sell |
36,362
-711,040
| -95% | -$53.5M | ﹤0.01% | 1529 |
|
|
2025
Q3 | $48.9M | Buy |
747,402
+264,113
| +55% | +$12.9M | 0.02% | 504 |
|
|
2025
Q2 | $19.1M | Sell |
483,289
-299,546
| -38% | -$9.8M | 0.01% | 741 |
|
|
2025
Q1 | $23.6M | Buy |
782,835
+470,689
| +151% | +$15.4M | 0.01% | 644 |
|
|
2024
Q4 | $10.9M | Buy |
312,146
+98,263
| +46% | +$3.67M | 0.01% | 960 |
|
|
2024
Q3 | $8.74M | Sell |
213,883
-6,635
| -3% | -$309K | ﹤0.01% | 1099 |
|
|
2024
Q2 | $10.5M | Sell |
220,518
-2,300
| -1% | -$94.3K | ﹤0.01% | 984 |
|
|
2024
Q1 | $10.5M | Sell |
222,818
-571
| -0.3% | -$27.2K | ﹤0.01% | 956 |
|
|
2023
Q4 | $11.3M | Sell |
223,389
-3,432
| -2% | -$164K | ﹤0.01% | 982 |
|
|
2023
Q3 | $10.1M | Buy |
226,821
+3,690
| +2% | +$152K | ﹤0.01% | 988 |
|
|
2023
Q2 | $9.28M | Buy |
223,131
+9,200
| +4% | +$354K | ﹤0.01% | 1037 |
|
|
2023
Q1 | $7.65M | Sell |
213,931
-8,047
| -4% | -$302K | ﹤0.01% | 1036 |
|
|
2022
Q4 | $9.21M | Sell |
221,978
-101,551
| -31% | -$4.27M | ﹤0.01% | 1021 |
|
|
2022
Q3 | $15.1K | Buy |
323,529
+91,537
| +39% | +$3.86M | 0.01% | 808 |
|
|
2022
Q2 | $9.22K | Sell |
231,992
-36,505
| -14% | -$1.38M | ﹤0.01% | 1106 |
|
|
2022
Q1 | $9.58M | Buy |
268,497
+39,090
| +17% | +$1.28M | ﹤0.01% | 1169 |
|
|
2021
Q4 | $7.17M | Sell |
229,407
-20,297
| -8% | -$639K | ﹤0.01% | 1092 |
|
|
2021
Q3 | $8.49M | Sell |
249,704
-131,781
| -35% | -$4.97M | ﹤0.01% | 1385 |
|
|
2021
Q2 | $15.1M | Buy |
381,485
+59,255
| +18% | +$2.32M | 0.01% | 1048 |
|
|
2021
Q1 | $13.8M | Sell |
322,230
-25,414
| -7% | -$1.42M | 0.01% | 852 |
|
|
2020
Q4 | $21.6M | Buy |
347,644
+13,472
| +4% | +$671K | 0.01% | 671 |
|
|
2020
Q3 | $15.1M | Sell |
334,172
-52,498
| -14% | -$2.92M | 0.01% | 687 |
|
|
2020
Q2 | $23.4M | Buy |
386,670
+46,226
| +14% | +$2.57M | 0.02% | 540 |
|
|
2020
Q1 | $16.7M | Buy |
340,444
+308,698
| +972% | +$17.2M | 0.02% | 550 |
|
|
2019
Q4 | $1.92M | Buy |
31,746
+6,058
| +24% | +$361K | ﹤0.01% | 1906 |
|
|
2019
Q3 | $1.54M | Buy |
25,688
+862
| +3% | +$56.2K | ﹤0.01% | 1853 |
|
|
2019
Q2 | $1.59M | Sell |
24,826
-8,310
| -25% | -$587K | ﹤0.01% | 1825 |
|
|
2019
Q1 | $2.69M | Sell |
33,136
-2,515
| -7% | -$162K | ﹤0.01% | 1502 |
|
|
2018
Q4 | $1.93M | Buy |
35,651
+17,386
| +95% | +$887K | ﹤0.01% | 1535 |
|
|
2018
Q3 | $942K | Sell |
18,265
-685
| -4% | -$32.2K | ﹤0.01% | 2032 |
|
|
2018
Q2 | $789K | Buy |
18,950
+1,288
| +7% | +$57.1K | ﹤0.01% | 2121 |
|
|
2018
Q1 | $779K | Buy |
17,662
+1,861
| +12% | +$94.5K | ﹤0.01% | 2035 |
|
|
2017
Q4 | $796K | Sell |
15,801
-10,017
| -39% | -$549K | ﹤0.01% | 2060 |
|
|
2017
Q3 | $1.31M | Buy |
25,818
+20,747
| +409% | +$1.09M | ﹤0.01% | 1848 |
|
|
2017
Q2 | $258K | Sell |
5,071
-926
| -15% | -$43.1K | ﹤0.01% | 2530 |
|
|
2017
Q1 | $242K | Sell |
5,997
-1,145
| -16% | -$51.4K | ﹤0.01% | 2372 |
|
|
2016
Q4 | $313K | Buy |
7,142
+1,920
| +37% | +$76K | ﹤0.01% | 2309 |
|
|
2016
Q3 | $191K | Sell |
5,222
-11,671
| -69% | -$365K | ﹤0.01% | 2481 |
|
|
2016
Q2 | $394K | Buy |
16,893
+68
| +0.4% | +$2.19K | ﹤0.01% | 2189 |
|
|
2016
Q1 | $682K | Sell |
16,825
-289
| -2% | -$11.7K | ﹤0.01% | 1916 |
|
|
2015
Q4 | $1.06M | Sell |
17,114
-39,440
| -70% | -$2.13M | ﹤0.01% | 1697 |
|
|
2015
Q3 | $2.29M | Sell |
56,554
-130,622
| -70% | -$6.76M | ﹤0.01% | 1244 |
|
|
2015
Q2 | $10.8M | Buy |
187,176
+136,770
| +271% | +$8.7M | 0.01% | 764 |
|
|
2015
Q1 | $3.21M | Buy |
50,406
+326
| +0.7% | +$22.1K | ﹤0.01% | 1187 |
|
|
2014
Q4 | $3.09M | Buy |
50,080
+11,524
| +30% | +$569K | ﹤0.01% | 1223 |
|
|
2014
Q3 | $1.5M | Buy |
38,556
+1,817
| +5% | +$64.4K | ﹤0.01% | 1585 |
|
|
2014
Q2 | $1.27M | Sell |
36,739
-12,548
| -25% | -$395K | ﹤0.01% | 1641 |
|
|
2014
Q1 | $2.13M | Buy |
49,287
+13,957
| +40% | +$677K | ﹤0.01% | 1308 |
|
|
2013
Q4 | $1.41M | Buy |
35,330
+18,771
| +113% | +$669K | ﹤0.01% | 1319 |
|
|
2013
Q3 | $622K | Sell |
16,559
-13,975
| -46% | -$417K | ﹤0.01% | 1696 |
|
|
2013
Q2 | $820K | Buy |
+30,534
| New | +$649K | ﹤0.01% | 1483 |
|
Other funds holding IONS
VPM
VCM
Bank of Montreal's IONS Position: Q1 2026 in Review
Bank of Montreal reduced its Ionis Pharmaceuticals (IONS) stake by 27% in Q1 2026, selling an estimated $772K and leaving 26,585 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #1669.
Bank of Montreal first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.9M in Q3 2025. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Bank of Montreal held 26,585 shares of Ionis Pharmaceuticals worth $2M as of Q1 2026.
- Bank of Montreal sold 9,777 Ionis Pharmaceuticals shares in Q1 2026, an estimated $772K.
- Ionis Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #1669 holding.
- Bank of Montreal first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's Ionis Pharmaceuticals position peaked at $48.9M in Q3 2025.
- 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.